देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE)
MYLAN PHARMACEUTICALS ULC
J01FF01
CLINDAMYCIN
150MG
CAPSULE
CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150MG
ORAL
100
Prescription
LINCOMYCINS
Active ingredient group (AIG) number: 0105830002; AHFS:
CANCELLED POST MARKET
2018-07-12
1 PRODUCT MONOGRAPH PR MYLAN-CLINDAMYCIN CLINDAMYCIN HYDROCHLORIDE CAPSULES USP CLINDAMYCIN 150 MG, 300 MG ANTIBIOTIC MYLAN PHARMACEUTICALS ULC 85 Advance Road Etobicoke, Ontario Canada, M8Z 2S6 DATE OF REVISION: November 14, 2017 Control No.: 197322 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................................ 3 SUMMARY PRODUCT INFORMATION ................................................................................ 3 INDICATIONS AND CLINICAL USE ...................................................................................... 3 CONTRAINDICATIONS ........................................................................................................... 4 WARNINGS AND PRECAUTIONS .......................................................................................... 5 ADVERSE REACTIONS ........................................................................................................... 8 DRUG INTERACTIONS .......................................................................................................... 10 DOSAGE AND ADMINISTRATION ...................................................................................... 11 OVERDOSAGE ........................................................................................................................ 13 ACTION AND CLINICAL PHARMACOLOGY .................................................................... 13 STORAGE AND STABILITY.................................................................................................. 16 DOSAGE FORMS, COMPOSITION AND PACKAGING ..................................................... 16 PART II: SCIENTIFIC INFORMATION .............................................................................. 17 PHARMACEUTICAL INFORMATION ................................................................................. 17 CLINICAL TRIALS ................................................................................................................. 18 DETAILED PHA पूरा दस्तावेज़ पढ़ें